Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon miRSIGN Oncogene and Colon Cancer Assays

Exiqon has launched the miRSIGN miR-21 Oncogene assay, a research-use-only kit for measuring miR-21 levels in relation to two reference microRNAs in formalin-fixed, paraffin-embedded tissue samples; and the miRSIGN Colon Cancer assay, an RUO kit for determining the presence of cancer cells in FFPE colon tissue samples.

Both kits are based on Exiqon's proprietary miRCURY LNA Universal RT microRNA PCR platform.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.